129 related articles for article (PubMed ID: 23894774)
1. [Serum level of selected chemokines in systemic lupus erythematosus patients taking into consideration the peripheral blood leukocyte counts].
Kopczyńska M; Franek A; Błaszczak E; Dworak J; Kopczyński P; Hrycek A
Pol Merkur Lekarski; 2013 May; 34(203):251-4. PubMed ID: 23894774
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus].
Tao JH; Li XP; Li XM; Kan M; Zhai ZM; Wang W
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3051-4. PubMed ID: 17288835
[TBL] [Abstract][Full Text] [Related]
3. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
4. Increased circulating CD11b+CD11c+ dendritic cells (DC) in aged BWF1 mice which can be matured by TNF-alpha into BLC/CXCL13-producing DC.
Ishikawa S; Nagai S; Sato T; Akadegawa K; Yoneyama H; Zhang YY; Onai N; Matsushima K
Eur J Immunol; 2002 Jul; 32(7):1881-7. PubMed ID: 12115607
[TBL] [Abstract][Full Text] [Related]
5. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Tam LS; Li EK; Lam CW
Ann Rheum Dis; 2006 Feb; 65(2):209-15. PubMed ID: 15975968
[TBL] [Abstract][Full Text] [Related]
6. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE).
Schiffer L; Kümpers P; Davalos-Misslitz AM; Haubitz M; Haller H; Anders HJ; Witte T; Schiffer M
Nephrol Dial Transplant; 2009 Dec; 24(12):3708-12. PubMed ID: 19602475
[TBL] [Abstract][Full Text] [Related]
7. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
Ezzat M; El-Gammasy T; Shaheen K; Shokr E
Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of beta-chemokines in systemic lupus erythematosus.
Kaneko H; Ogasawara H; Naito T; Akimoto H; Lee S; Hishikawa T; Sekigawa I; Tokano Y; Takasaki Y; Hirose SI; Hashimoto H
J Rheumatol; 1999 Mar; 26(3):568-73. PubMed ID: 10090164
[TBL] [Abstract][Full Text] [Related]
9. Serum chemokines RANTES and monocyte chemoattractant protein-1 in Egyptian patients with atopic asthma: relationship to disease severity.
Saad-El-Din Bessa S; Abo El-Magd GH; Mabrouk MM
Arch Med Res; 2012 Jan; 43(1):36-41. PubMed ID: 22300682
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of selected chemokines in systemic lupus erythematosus patients.
Hrycek E; Franek A; Błaszczak E; Dworak J; Hrycek A
Rheumatol Int; 2013 Sep; 33(9):2423-7. PubMed ID: 22461186
[TBL] [Abstract][Full Text] [Related]
11. B-cell-attracting chemokine-1 (BCA-1/CXCL13) in systemic lupus erythematosus, its correlation to disease activity and renal involvement.
Hafez SS; Saad Wel S; Shedid NH
Egypt J Immunol; 2014; 21(2):23-32. PubMed ID: 25812350
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Henneken M; Dörner T; Burmester GR; Berek C
Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
[TBL] [Abstract][Full Text] [Related]
13. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
14. Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus.
Vilá LM; Molina MJ; Mayor AM; Cruz JJ; Ríos-Olivares E; Ríos Z
Clin Rheumatol; 2007 May; 26(5):718-22. PubMed ID: 16924394
[TBL] [Abstract][Full Text] [Related]
15. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis.
Shah D; Wanchu A; Bhatnagar A
Immunobiology; 2011 Sep; 216(9):1010-7. PubMed ID: 21601309
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
17. Elevation of serum CXCL13 in SLE as well as in sepsis.
Schiffer L; Kielstein JT; Haubitz M; Lührs H; Witte T; Haller H; Kümpers P; Schiffer M
Lupus; 2011 Apr; 20(5):507-11. PubMed ID: 21078761
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy-associated inflammatory markers are elevated in pregnant women with systemic lupus erythematosus.
Björkander S; Bremme K; Persson JO; van Vollenhoven RF; Sverremark-Ekström E; Holmlund U
Cytokine; 2012 Aug; 59(2):392-9. PubMed ID: 22633082
[TBL] [Abstract][Full Text] [Related]
19. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H
Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025
[TBL] [Abstract][Full Text] [Related]
20. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]